Tomasz Ł.
- Country
- Poland
- Department
- Gynecology
Research Overview
- Evaluation of Contraceptive Efficacy, Safety and Tolerability of Oral Drospirenone 4 mg (LPRI‑CF113) Over 13 Cycles: Multicentre Open‑Label Single‑Arm Study
- Efficacy, Safety, and Pharmacokinetics of Single-Dose Albaconazole Versus Fluconazole and Placebo in Acute Vulvovaginal Candidiasis
- A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.
Data & Insights
Has run more than one trial at 24 of 102 partner sites.
Specializations
Women's Health and Gynecology
The investigator specializes in women's reproductive health conditions, with particular emphasis on vaginal infections and contraceptive medicine.
- Vulvovaginal Candidiasis Treatment
- Contraceptive Technologies
- Reproductive Health Management
This clinical researcher focuses on evaluating innovative therapeutic approaches for common gynecological conditions and advancing contraceptive solutions.
Infectious Disease Management
The investigator has developed expertise in treating fungal infections, particularly those affecting the female reproductive system.
- Antifungal Therapeutics
- Clinical Mycology
- Treatment Optimization
Their work encompasses the evaluation of novel antifungal agents and comparative treatment approaches.
Reproductive Medicine
The investigator explores long-acting contraceptive methods and innovative delivery systems for reproductive health management.
- Hormonal Delivery Systems
- Contraceptive Efficacy
- Women's Healthcare Innovation
Their research includes assessment of novel contraceptive technologies and delivery mechanisms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
